tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Catherine Novack, 1 are a BUY (50%), 1 are a HOLD (50%).
Analyst Catherine Novack works at JONESTRADING
Catherine Novack’s has documented 3 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on KZR, Kezar Life Sciences at 05-Oct-2023.
Analyst best performing recommendations are on KZR (KEZAR LIFE SCIENCES).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
5 months 22 days ago
0/1 (0%)
$4.29 (250.88%)
Buy
4
$3.46 (640.74%)
2 years 3 months 14 days ago
0/1 (0%)
$2.38 (146.91%)
Buy
9
$8.46 (1566.67%)
2 years 10 months 2 days ago
0/1 (0%)
$7.11 (376.19%)
What Year was the first public recommendation made by Catherine Novack?
